Skip to main content
ARDELYX, INC. logo

ARDELYX, INC. — Investor Relations & Filings

Ticker · ARDX ISIN · US0396971071 LEI · 549300F542QR4SXHCY32 US Manufacturing
Filings indexed 1,078 across all filing types
Latest filing 2016-03-04 Annual Report
Country US United States of America
Listing US ARDX

About ARDELYX, INC.

https://www.ardelyx.com/

Ardelyx, Inc. is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines to address unmet medical needs. The company's primary therapeutic areas of focus are cardiorenal and gastrointestinal diseases. Its key commercial product is XPHOZAH® (tenapanor), a novel mechanism therapy for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Ardelyx also develops treatments for Irritable Bowel Syndrome with Constipation (IBS-C), aiming to advance patient care through its portfolio of innovative therapies.

Recent filings

Filing Released Lang Actions
10-K
Annual Report FY 2015
2016-03-04 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 4, 2016, reporting the company's financial results for the fourth quarter and year ended December 31, 2015. It specifically states that the full text of the press release is furnished as an exhibit and that the information is not considered filed under the Securities Exchange Act. The document is short (2688 characters) and primarily announces the earnings release rather than containing detailed financial statements or analysis. According to the rules, initial announcements of quarterly or periodical financial results (key highlights only) are classified as Earnings Release (ER).
2016-03-04 English
FORM 4
Director's Dealing
2016-02-19 English
SC 13G/A
Major Shareholding Notification
2016-02-16 English
Major Shareholding Notification 2016
Major Shareholding Notification
2016-02-16 English
Major Shareholding Notification 2016
Major Shareholding Notification
2016-02-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.